Sort
85,873 grants matching “alzheimers”
Blood-based Biomarker for Characterizing Progression and Therapeutic Response in Amyotrophic Lateral Sclerosis
$2,147,016Erez Eitan · Neurodex Inc · R44 · FY2024 · NS
Translational Science Engaging North Dakota (TRANSCEND)
$2,146,647Gary G Schwartz · University Of North Dakota · P20 · FY2025 · GM
Clinical and Biological Studies of Early AD
$2,146,611Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · AG
Substrate Feedback Mechanism of gamma-Secretase
$2,146,250Yueming Li · Sloan-Kettering Inst Can Research · RF1 · FY2018 · AG
Dominantly Inherited Alzheimer Network: Clinical Core
$2,145,092John Morris · Washington University · U19 · FY2023 · AG
Alzheimer's Disease Research Center at Columbia Univ.
$2,144,602Michael Shelanski · Columbia University Health Sciences · P50 · FY2007 · AG
Model-based cerebrovascular markers extracted from hemodynamic data for diagnosing MCI or AD and predicting disease progression.
$2,144,503Vasilis Z Marmarelis · University Of Southern California · R01 · FY2018 · AG
The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease
$2,144,415Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
A Pilot Electroencephalography (EEG) Study to Evaluate the Effect of CT1812 Treatment on Synaptic Activity in Subjects with Mild to Moderate Alzheimerʼs Disease
$2,144,409Anthony O Caggiano · Cognition Therapeutics, Inc. · RF1 · FY2022 · AG
Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis
$2,144,276Myriam Gorospe · National Institute On Aging · ZIA · FY2020 · AG
Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD
$2,143,493Kathleen M Hayden · Wake Forest University Health Sciences · R01 · FY2022 · AG
Processing Of Oxidative Stress In Alzheimer
$2,142,169Vilhelm A Bohr · National Institute On Aging · ZIA · FY2019 · AG
Discovery of Chemical Probes and Therapeutic Leads
$2,141,350Joseph M Fox · University Of Delaware · P20 · FY2017 · GM
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
$2,140,865Daniel F Hanley · Johns Hopkins University · R01 · FY2024 · AG
Neuroimaging Analysis Center
$2,140,298Ron Kikinis · Brigham And Women'S Hospital · P41 · FY2010 · RR
Alzheimer Disease Research Center
$2,140,244Helena Chang Chui · University Of Southern California · P50 · FY2012 · AG
Brain Bank Genome Sequencing - Exploring Alzheimer's disease related dementias
$2,140,206Andrew Singleton · National Institute On Aging · ZIA · FY2022 · AG
Elucidating the Role of Endothelial Dysfunction in Alzheimer Disease: Towards A New Data-Driven Disease Model
$2,140,130Rawan Tarawneh · University Of New Mexico Health Scis Ctr · RF1 · FY2023 · AG
BACE1 in neurodegeneration and neurological dysfunction
$2,139,908Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2021 · NS
Health Disparities in Alzheimer's Disease Among Mexican Americans
$2,139,734Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R56 · FY2016 · AG
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 3)
$2,138,236William S Kremen · University Of California, San Diego · R01 · FY2018 · AG
University of Kentucky Alzheimer's Disease Core Center
$2,138,054Linda J Van Eldik · University Of Kentucky · P30 · FY2020 · AG
Mathematical modeling of selective vulnerability of genes, cells and network in mouse tauopathy
$2,138,027Ashish Raj · University Of California, San Francisco · RF1 · FY2024 · AG
Emergency Care Redesign (ECR)
$2,136,433Joshua Chodosh · New York University School Of Medicine · U19 · FY2024 · AG
Regulation of CHCHD6 in Alzheimer's disease
$2,136,033Xin Qi · Case Western Reserve University · RF1 · FY2022 · AG